Replies to post #32613 on Cytodyn Inc (CYDY)

[misiu143]

Rwshay -Happy New Year....Even with phase 3 combo for HIV , Maraviroc needed about 2000 patients to enrolled ( I believe ) and study took 5 years .
PE was done after 2 years on study in contrary to 1 week for Leronlimab .

I believe this was because from the beginning serious side effects with Maraviroc , and at the end of study efficacy about 45% , in contrary to not one serious side effect with Leronlimab , and at the end efficacy of 81%.

In medicine no serious side effects is giant ....
I can’t think of another medicine without at least possibilities of developing serious problems ..

But I do believe all the studies BP does with Maraviroc helping cydy to figure out what diseases to go after .

After they used Maraviroc for GvHD , dr NP decided to try with Pro 140.
Also dr Pestell did first pre-clinical studies for cancers with Maraviroc.

At the end , everyone in medical profession , like dr Pestell did , will notice the difference between those two drugs ...

IMO as always ..

[Inoviorulez]

maraviroc was on old drug already approved, Pfizer and Merck are each working on a new CCR5 cancer drug.